AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75A50121C00060BIOAEGIS THERAPEUTICS INC
Overview
Award facts
- Net obligations
- $749K
- $749,000of $749K potential value
- Outlays (paid to date)
- $749K
- $749K paid of $749K obligated$749,000
- Period of performance
- Jun 11, 2021 to Mar 31, 2023
- Ended
- Modifications
- 6
- Latest action Dec 8, 2022
- Contract type
- Definitive contract
- PIID 75A50121C00060
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
DEVELOP A SAFE AND EFFECTIVE THERAPEUTIC TO MITIGATE SEVERE OUTCOMES, INCLUDING BUT NOT LIMITED TO MORTALITY, IN PATIENTS WITH SEVERE INFECTION OR SEPSIS OF ANY ETIOLOGY.
Dates and value
- Award date
- Signed on Jun 11, 2021
- Potential end of performance
- Mar 30, 2023
- Current value
- $749,000Base and exercised options
- Potential value (if all options are exercised)
- $749,000
Obligations by fiscal year of action
- FY2021: $749,000
Total across 1 fiscal year: $749,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 8, 2022. View on USAspending · Recipient on SAM.gov
Recipient
LocationMORRISTOWN, NJ
UEIG2AZAC2PG7X3
CAGE code6QA91
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyBIOAEGIS THERAPEUTICS INC
Business types and certifications
Self-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Morristown, Morris County, New Jersey 07960-3998
- Congressional district (place of performance)
- NJ-11As reported at the time of the action
Classification and competition
Classification
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 10
Solicitation and notices
- Solicitation ID
- BAA-20-100-SOL-0002
- Solicitation date
- Feb 3, 2020
- Notices
- Solicitation posted Oct 18, 2022
- Solicitation posted Jun 24, 2022
- Solicitation posted Mar 31, 2022
- Solicitation posted Jan 7, 2022
- Solicitation posted Nov 24, 2021
- Solicitation posted Nov 10, 2021
- Solicitation posted Aug 23, 2021
- Solicitation posted Aug 23, 2021
- Solicitation posted Mar 4, 2021
- Solicitation posted Mar 4, 2021
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Bioaegis - recombinant human plasma gelsolin, a host-based pathogen agnostic therapeutic for severe
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jun 11, 2021Base obligation at award: $749,000
- Latest action
- Dec 8, 2022 — Supplemental agreement (within scope)Modification P00006
- Latest substantive action
- Dec 8, 2022 — Supplemental agreement (within scope)Modification P00006
- Actions by type
- Base award1
- Supplemental agreement (within scope)3
- Other administrative action3
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- Environmentally preferableF
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Contingency, humanitarian or peacekeeping operation
- Presidential issued emergency declaration, or a major disaster declarationC
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 7
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-2021/2022-0140-000
- Object classes
- 25.1: Advisory and assistance services
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression